Žádné výsledky... Zkuste upravit dotaz a/nebo upravit či vypnout filtry.
Monitoring and surveillance
Dotaz
Zobrazit nápovědu
1. Autor: Ibrahim, Ibrahim
MeSH:
lichen nitidus-mikrobiologie
Pracoviště:
HES SO University of Applied Sciences and Arts ...
MeSH:
Professional Practice-economics
Organizace:
Association of Cancer Physicians
MeSH:
Cancer-Associated Fibroblasts-virology
MeSH:
Bendroflumethiazide-radiation effects
MeSH:
Dexetimide-administration & dosage
Pracoviště:
Genitourinary Oncology Program Moffitt Cancer C...
Autor:
Evers, David C
MeSH:
polyribonukleotidy-klasifikace
Nejvíce citované:
37931634
Nejvíce citovaný článek - PubMed ID 37931634
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Lancet (London, England).
2023 Dec 02 ;
402 (10417) :
2077-2090.
[epub] 20231103
